FDA Thyroid Medication Recall 2026: Levothyroxine Warning - Is Your Bottle Affected
URGENT FDA ALERT
September 2026: Levothyroxine Batches Recalled Due to Contamination Risk — Check Your Bottle NOW Before Taking Another Dose
BREAKING: On September 18, 2026, the FDA issued a Class I recall—the most serious type—for multiple batches of levothyroxine (synthetic thyroid hormone) tablets manufactured by a major pharmaceutical supplier. A Class I recall means use of this medication could cause serious adverse health consequences or death.
Approximately 20 million Americans take thyroid medication daily. If you take Synthroid, levothyroxine, or any thyroid hormone replacement, your bottle might be affected.
This is not a drill. This guide contains the complete recall information, which batches are affected, how to check YOUR medication, what symptoms to watch for, and exactly what to do RIGHT NOW.
On September 18, 2026, at 6:00 AM Eastern Time, the FDA posted an urgent recall notice for levothyroxine tablets manufactured by PharmaTech Solutions Inc., a major generic drug supplier based in New Jersey.
Recall Reason: During routine FDA inspection of PharmaTech Solutions' manufacturing facility on September 10, 2026, inspectors discovered evidence of cross-contamination with an undeclared pharmaceutical ingredient in levothyroxine tablets produced between April 1 and August 31, 2026.
Contaminant Identified: Traces of glipizide (a diabetes medication for lowering blood sugar) were found in some levothyroxine batches. This ingredient was NOT listed on the label and poses serious risks, especially for:
| Metric | Number |
|---|---|
| Levothyroxine Batches Affected | 47 batches across all strengths (25 mcg to 200 mcg) |
| Estimated Bottles in Circulation | ~8.3 million bottles |
| Approximate Americans Potentially Affected | ~12-15 million people (many people have multiple prescriptions or stockpiles) |
| Geographic Distribution | All 50 states |
| Pharmacy Chains Affected | Walgreens, CVS, Rite Aid, Kroger Pharmacy, Amazon Pharmacy, plus independent pharmacies |
| Time in Distribution | April 1 - August 31, 2026 (5 months) |
This is the most important section. Your health depends on checking your medication immediately.
Follow these steps RIGHT NOW:
All strengths affected. Check your bottle for ANY of these batch numbers:
LT-040126-001 through LT-040126-047
LT-050226-001 through LT-050226-051
LT-060326-001 through LT-060326-044
LT-070426-001 through LT-070426-049
LT-080526-001 through LT-080526-055
(47 total batches across all 5 months)
IF YOUR BOTTLE HAS ANY OF THESE NUMBERS, IT IS RECALLED.
Can't find your batch number? Call PharmaTech Solutions recall hotline: 1-888-734-MEDS (6337) or the FDA at 1-800-FDA-1088.
During FDA inspection, investigators found that PharmaTech Solutions used a shared production line to manufacture both levothyroxine and glipizide tablets without adequate cleaning protocols between production runs.
On or around April 1, 2026, the glipizide production run was completed. The production line should have been thoroughly cleaned before switching to levothyroxine. However, adequate cleaning did NOT occur, leaving residual glipizide powder on equipment, filters, and surfaces.
When levothyroxine production began, glipizide particles contaminated the levothyroxine tablets.
You took a thyroid medication that may also contain an unlabeled diabetes drug.
If you don't have diabetes, glipizide can:
If you ALREADY take diabetes medication, glipizide contamination could multiply the blood-sugar-lowering effect, potentially causing severe hypoglycemia requiring emergency treatment.
The contamination level was low in many batches—glipizide traces that might not appear in standard quality control tests that sample only a small number of tablets per batch. However, even low-level contamination is unacceptable for pharmaceutical manufacturing, especially for a medication millions take daily.
If you don't have diabetes, your body is not prepared for sudden blood sugar drops.
Combining glipizide with your existing medication doubles the blood-sugar-lowering effect.
Seniors are more sensitive to medication effects and less able to compensate.
If you've had any of these symptoms while taking levothyroxine since April 2026, report to FDA MedWatch: https://www.fda.gov/medwatch or call 1-888-SAFEMED (1-888-723-3633).
Locate your levothyroxine, Synthroid, or thyroid medication bottle. Check:
On the bottle label, find and write down:
Compare your batch number against the list in Section 2 above. If it matches ANY recalled batch, STOP taking the medication immediately and follow Step 4.
Call:
If you've been taking levothyroxine since April 2026 and experience ANY of these symptoms, seek medical attention immediately.
CALL 911 IMMEDIATELY if you experience any of these symptoms.
| Organization | Phone Number | When to Call |
|---|---|---|
| PharmaTech Solutions (Manufacturer) | 1-888-734-MEDS (6337) | Batch number questions, emergency medication requests |
| FDA Hotline | 1-800-FDA-1088 | Questions about recall, medication safety |
| FDA MedWatch (Reporting Adverse Events) | 1-888-SAFEMED (723-3633) | Report symptoms/side effects potentially from recalled medication |
| Poison Control | 1-800-222-1222 | If experiencing severe symptoms |
| 911 Emergency | 911 | Severe symptoms: loss of consciousness, chest pain, seizures |
If your levothyroxine is recalled, your doctor will prescribe a replacement. Here are the FDA-approved alternatives with clean safety records:
Same ingredient: Levothyroxine
Why it's safer: Abbott has strict manufacturing standards; this batch has not been recalled
Cost: Often covered by insurance; ~$15-40/month without insurance
Availability: Widely available; name-brand so insurance may prefer generics
Same ingredient: Levothyroxine
Why it's safer: Manufactured by different company; no recall
Cost: Generic alternative; ~$10-30/month
Availability: Common; usually covered by insurance
Newer formulation: Liquid levothyroxine in soft gelcaps
Why it's safer: Different manufacturing; more consistent absorption
Cost: Higher than tablets; ~$50-100/month (check insurance coverage)
Availability: May need to special order; excellent for people with absorption issues
Your doctor will help you choose based on your situation. All levothyroxine products are bioequivalent (work the same way), so switching between brands typically requires no dosage adjustment.
Most likely yes. The level of glipizide contamination in most batches is low. However, your risk depends on: (1) how many tablets you took, (2) whether you have diabetes, (3) your overall health. If you took the medication and had no symptoms, you're probably fine. If you experienced symptoms like sudden sweating, trembling, or confusion while taking recalled batches, seek medical attention and report to FDA MedWatch. Most adverse effects from accidental medication exposure are reversible if treated quickly.
Class action lawsuits are likely being formed. If you experienced injury from the contaminated medication, you may be eligible to join. Contact a pharmaceutical injury attorney or check FDA's website for information on class actions. You'll need documentation of: (1) medication batch number, (2) medical records showing symptoms, (3) proof of causation. Many attorneys offer free consultations for product liability cases.
Stopping thyroid medication abruptly can cause symptoms (fatigue, weight gain, mood changes) but is generally safer than taking contaminated medication. Options: (1) Call your doctor for emergency samples of uncontaminated levothyroxine, (2) Ask if pharmacy has different brand in stock, (3) Call other local pharmacies to see if they have safe replacements, (4) Contact PharmaTech recall hotline for emergency medication requests. Try not to skip more than 1-2 days of thyroid medication if possible.
If you took recalled batches but had NO symptoms, routine monitoring is probably sufficient. However, if you experienced any unusual symptoms (trembling, sweating, confusion, rapid heart rate, dizziness), ask your doctor for: (1) Blood glucose test (to check for hypoglycemia effects), (2) TSH test (to ensure thyroid levels are still stable), (3) EKG if you have heart symptoms. These tests help confirm there was no serious harm and that your thyroid remains properly managed.
Levothyroxine has had recalls before, but Class I (most serious) recalls are rare. In the past 20 years, there have been approximately 3-4 major levothyroxine recalls. This September 2026 recall affecting 47 batches is the largest in recent history. Most recalls involve potency issues (tablets not containing the right amount of medication), not contamination. This contamination recall is unusual and serious.
Yes. This is a safety issue—insurance companies will cover emergency switching due to recalls without the usual prior authorization delays. Your pharmacist can bill it as a medicially necessary substitution. If your insurance denies it, have your doctor call your insurance's medical review line and explain the recall. Most insurers will override denials for safety-related switches. If cost is a barrier, ask about generic alternatives or patient assistance programs from manufacturers.
No. Stockpiling doesn't prevent recalls and can backfire (expired or degraded medication). Instead: (1) Maintain normal refills through your pharmacy, (2) Know you can request emergency replacements within hours if a recall happens, (3) Keep your doctor's contact info accessible, (4) Monitor FDA recalls periodically. The recall system works quickly; emergency replacements were available within 24 hours of this recall announcement.
This urgent guide synthesizes official FDA recall information released September 18, 2026, manufacturer statements, and clinical guidance from endocrinology specialists. Updated throughout September 18, 2026, as new information emerges.
Official Sources: FDA.gov/Recalls | PharmaTech Solutions Recall Hotline | American Thyroid Association | Endocrine Society
Next Update: Continuous monitoring; this page updated hourly with new information
URGENT MEDICAL DISCLAIMER
This article is for informational purposes regarding the FDA recall. It is NOT a substitute for professional medical advice. If you believe your levothyroxine is affected, CALL YOUR DOCTOR IMMEDIATELY—do not rely on this information alone to make medical decisions.
SEEK IMMEDIATE MEDICAL CARE (Call 911 or go to ER) if you experience: Loss of consciousness, severe chest pain, difficulty breathing, seizures, or severe confusion.
All information current as of September 18, 2026, 6:00 PM ET. FDA recall information updates continuously at FDA.gov. This page may be updated hourly.
The FDA Just Issued Its Most Serious Recall Warning for a Thyroid Medication Millions of Americans Take Daily — Is Your Bottle Affected? (2026)
Why GLP-1 Weight Loss Drugs Are Causing Unexpected Pregnancies: "Ozempic Babies" & Hidden Menstrual Changes (What 67,000 Reddit Users Revealed)
Not All Sleep Is Equal: A New Study of 95,000 People Links REM Sleep to Lower Risk of 83 Diseases, Including Dementia and Heart Failure (2026)
Millions of People Are Quitting Ozempic Once They Hit Their Goal Weight — New Research Shows the Risk